{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:11:15Z","timestamp":1762506675361,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.soc.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T04:45:14Z","timestamp":1448253914000},"page":"77-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Asymptomatic Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"25","author":[{"given":"James X.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2015.08.004_bib1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib2","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jcem-48-3-393","article-title":"Relationship of free and total calcium in hypercalcemic conditions","volume":"48","author":"Ladenson","year":"1979","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib4","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","article-title":"The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism","volume":"97","author":"Ong","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib5","first-page":"173","article-title":"High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria","volume":"28","author":"Glendenning","year":"1998","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.soc.2015.08.004_bib6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/j.soc.2015.08.004_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of bovine and human parathyroid hormone","volume":"49","author":"Berson","year":"1963","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.soc.2015.08.004_bib8","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1210\/jc.2005-0715","article-title":"Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism","volume":"90","author":"Boudou","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib9","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2009-2791","article-title":"The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma","volume":"95","author":"Cavalier","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.clinbiochem.2013.01.016","article-title":"Comparison of the Elecsys PTH (1\u201384) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients","volume":"46","author":"Tan","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.soc.2015.08.004_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.soc.2015.08.004_bib12","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","article-title":"Prevalence and correlates of vitamin D deficiency in US adults","volume":"31","author":"Forrest","year":"2011","journal-title":"Nutr Res"},{"key":"10.1016\/j.soc.2015.08.004_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00223-004-0025-0","article-title":"Vitamin D insufficiency in internal medicine residents","volume":"76","author":"Haney","year":"2005","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.soc.2015.08.004_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gassur.2003.09.020","article-title":"Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery","volume":"8","author":"Slater","year":"2004","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.soc.2015.08.004_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.sla.0000216773.47825.c1","article-title":"The long-term effects of gastric bypass on vitamin D metabolism","volume":"243","author":"Johnson","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2015.08.004_bib17","doi-asserted-by":"crossref","first-page":"E599","DOI":"10.1002\/oby.20464","article-title":"Serum 25 (OH) vitamin D concentration changes after Roux-en-Y gastric bypass surgery","volume":"21","author":"Beckman","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.soc.2015.08.004_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11695-013-1104-y","article-title":"Vitamin D status 10 years after primary gastric bypass: gravely high prevalence of hypovitaminosis D and raised PTH levels","volume":"24","author":"Karefylakis","year":"2014","journal-title":"Obes Surg"},{"issue":"8","key":"10.1016\/j.soc.2015.08.004_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/jbmr.2467","article-title":"Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status","volume":"30","author":"Schafer","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.soc.2015.08.004_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002230001201","article-title":"The prevalence of familial hypocalciuric hypercalcemia","volume":"68","author":"Hinnie","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.soc.2015.08.004_bib21","first-page":"217","article-title":"Familial hypocalciuric hypercalcemia","volume":"2","author":"Marx","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.soc.2015.08.004_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2015.08.004_bib23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.surg.2012.08.015","article-title":"Changes in bone mineral density after surgical intervention for primary hyperparathyroidism","volume":"152","author":"Dy","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2015.08.004_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00268-008-9720-8","article-title":"Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism","volume":"33","author":"VanderWalde","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.soc.2015.08.004_bib25","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib26","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib27","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.sla.0000120072.85692.a7","article-title":"The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?","volume":"239","author":"Eigelberger","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2015.08.004_bib29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","article-title":"Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \u201casymptomatic\u201d primary hyperparathyroidism","volume":"146","author":"Perrier","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2015.08.004_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A\u00a0record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"75","author":"Yu","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.soc.2015.08.004_bib31","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/SLA.0000000000000812","article-title":"Trends in the frequency and quality of parathyroid surgery: analysis of 17,082 cases over 10 years","volume":"261","author":"Abdulla","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2015.08.004_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"NIH conference-diagnosis and management of asymptomatic primary hyperparathyroidism\u2014consenus development conference statement","volume":"114","author":"Potts","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.soc.2015.08.004_bib33","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.soc.2015.08.004_bib34","first-page":"S9","article-title":"Consensus development conference statement","volume":"6","year":"1991","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.soc.2015.08.004_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.soc.2015.08.004_bib37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1634\/theoncologist.2011-0285","article-title":"What is the utility of distal forearm DXA in primary hyperparathyroidism?","volume":"17","author":"Wood","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.soc.2015.08.004_bib38","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.soc.2015.08.004_bib40","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.soc.2015.08.004_bib41","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.soc.2015.08.004_bib42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00198-013-2502-7","article-title":"Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range","volume":"25","author":"Nassar","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.soc.2015.08.004_bib44","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2012-4255","article-title":"Trabecular bone score (TBS)\u2013a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism","volume":"98","author":"Silva","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-13-0305","article-title":"Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.soc.2015.08.004_bib46","first-page":"869","article-title":"Clinical practice guidelines for chronic kidney disease in adults: part I. Definition, disease stages, evaluation, treatment, and risk factors","volume":"70","author":"Johnson","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.soc.2015.08.004_bib47","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1210\/jc.2009-0587","article-title":"Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism","volume":"94","author":"Tassone","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib48","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1210\/jc.2011-3072","article-title":"Effect of renal function on skeletal health in primary hyperparathyroidism","volume":"97","author":"Walker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP14074.OR","article-title":"Silent renal stones in primary hyperparathyroidism: prevalence and clinical features","volume":"20","author":"Cassibba","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.soc.2015.08.004_bib50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9343(02)01306-2","article-title":"Age as a criterion for surgery in primary hyperparathyroidism","volume":"113","author":"Silverberg","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.soc.2015.08.004_bib51","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A\u00a010-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2015.08.004_bib52","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-2819","article-title":"Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism","volume":"95","author":"Wu","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s002689900431","article-title":"Parathyroidectomy in the elderly: do the benefits outweigh the risks?","volume":"22","author":"Chen","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.soc.2015.08.004_bib54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jss.2007.01.027","article-title":"Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk\u2013benefit analysis","volume":"140","author":"Egan","year":"2007","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.soc.2015.08.004_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cen.12206","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"79","author":"Yu","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.soc.2015.08.004_bib56","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib57","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/jc.2011-0238","article-title":"Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers","volume":"96","author":"Farahnak","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib58","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.soc.2015.08.004_bib60","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-12-0124","article-title":"Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism","volume":"167","author":"Walker","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.soc.2015.08.004_bib62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2265.2011.04197.x","article-title":"The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism","volume":"76","author":"Kahal","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.soc.2015.08.004_bib63","doi-asserted-by":"crossref","first-page":"E1737","DOI":"10.1210\/jc.2011-1486","article-title":"Depression in primary hyperparathyroidism: prevalence and benefit of surgery","volume":"96","author":"Espiritu","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2015.08.004_bib64","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.sla.0000186337.83407.ec","article-title":"Primary hyperparathyroidism, cognition, and health-related quality of life","volume":"242","author":"Coker","year":"2005","journal-title":"Ann Surg"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320715000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320715000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:01:21Z","timestamp":1760961681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320715000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1055320715000770"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2015.08.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymptomatic Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}